{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:13:44Z","timestamp":1778030024676,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Xingtai City Science and Technology Plan Project","award":["No. 2019ZC175"],"award-info":[{"award-number":["No. 2019ZC175"]}]},{"name":"the Xingtai City Science and Technology Plan Project","award":["No. 2019ZC175"],"award-info":[{"award-number":["No. 2019ZC175"]}]},{"name":"the Xingtai City Science and Technology Plan Project","award":["No. 2019ZC175"],"award-info":[{"award-number":["No. 2019ZC175"]}]},{"name":"the Xingtai City Science and Technology Plan Project","award":["No. 2019ZC175"],"award-info":[{"award-number":["No. 2019ZC175"]}]},{"name":"the Xingtai City Science and Technology Plan Project","award":["No. 2019ZC175"],"award-info":[{"award-number":["No. 2019ZC175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04813-8","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:43:37Z","timestamp":1774590217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polo-like kinase 5 is lowly expressed and negatively correlates with poorer differentiation, and its positivity may predict a better prognosis in patients with colorectal cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Xianying","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinpeng","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"3","key":"4813_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4813_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cac2.12639","volume":"45","author":"F Wang","year":"2025","unstructured":"Wang F, Chen G, Zhang Z, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update. Cancer Commun (Lond). 2025;45(3):332\u201379.","journal-title":"Cancer Commun (Lond)"},{"issue":"20","key":"4813_CR3","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1038\/onc.2016.438","volume":"36","author":"H Wu","year":"2017","unstructured":"Wu H, Zhang XY, Hu Z, et al. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing. Oncogene. 2017;36(20):2857\u201367.","journal-title":"Oncogene"},{"issue":"12","key":"4813_CR4","doi-asserted-by":"publisher","first-page":"107118","DOI":"10.1016\/j.ejso.2023.107118","volume":"49","author":"Z Xie","year":"2023","unstructured":"Xie Z, Zhang Q, Wang X, et al. Development and validation of a novel radiomics nomogram for prediction of early recurrence in colorectal cancer. Eur J Surg Oncol. 2023;49(12):107118.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"4813_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12029-023-00990-9","volume":"55","author":"SH Hoseini","year":"2024","unstructured":"Hoseini SH, Enayati P, Nazari M, et al. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective. J Gastrointest cancer. 2024;55(2):497\u2013510.","journal-title":"J Gastrointest cancer"},{"key":"4813_CR6","doi-asserted-by":"crossref","unstructured":"Ashouri K, Wong A, Mittal P et al. Exploring predictive and prognostic biomarkers in colorectal cancer: a comprehensive review. Cancers (Basel). 2024;16 (16):2796.","DOI":"10.3390\/cancers16162796"},{"issue":"7","key":"4813_CR7","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.clinre.2025.102611","volume":"49","author":"E Vo-Quang","year":"2025","unstructured":"Vo-Quang E, Gandini A, Taly V, et al. Circulating tumor DNA: A new tool to predict recurrence and guide treatment of colorectal cancer. Clin Res Hepatol Gastroenterol. 2025;49(7):102611.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"Suppl 4","key":"4813_CR8","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.47391\/JPMA.EGY-S4-26","volume":"73","author":"EM Ahmed Nor","year":"2023","unstructured":"Ahmed Nor EM, Saied EM, Mina SN, et al. Clinicopathological Value Of Epidermal Growth Factor Receptor (EGFR) And Ki-67 Expression In Colorectal Adenoma And Adenocarcinoma. JPMA. J Pak Med Assoc. 2023;73(Suppl 4):S124\u201330.","journal-title":"J Pak Med Assoc"},{"key":"4813_CR9","doi-asserted-by":"crossref","unstructured":"Radi\u0107 J, Nikoli\u0107 I, Kolarov-Bjelobrk I et al. Prognostic and predictive significance of primary tumor localization and HER2 expression in the treatment of patients with KRAS Wild-Type metastatic colorectal cancer: single-centre experience from Serbia. J Pers Med. 2024;14 (8):879.","DOI":"10.3390\/jpm14080879"},{"issue":"14","key":"4813_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","volume":"10","author":"G de C\u00e1rcer","year":"2011","unstructured":"de C\u00e1rcer G, Manning G, Malumbres M. From Plk1 to Plk5: functional evolution of polo-like kinases. Cell Cycle. 2011;10(14):2255\u201362.","journal-title":"Cell Cycle"},{"issue":"9","key":"4813_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/13543776.2024.2379924","volume":"34","author":"S Bian","year":"2024","unstructured":"Bian S, Zhang R, Nie J, et al. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018-present). Expert Opin Ther Pat. 2024;34(9):789\u2013806.","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"4813_CR12","doi-asserted-by":"publisher","first-page":"188971","DOI":"10.1016\/j.bbcan.2023.188971","volume":"1878","author":"N Zheng","year":"2023","unstructured":"Zheng N, Wei J, Wu D, et al. Master kinase PDK1 in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2023;1878(6):188971.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"4813_CR13","doi-asserted-by":"publisher","first-page":"188467","DOI":"10.1016\/j.bbcan.2020.188467","volume":"1875","author":"CA Raab","year":"2021","unstructured":"Raab CA, Raab M, Becker S, et al. Non-mitotic functions of polo-like kinases in cancer cells. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188467.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"4813_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/MCB.00607-10","volume":"31","author":"G de C\u00e1rcer","year":"2011","unstructured":"de C\u00e1rcer G, Escobar B, Higuero AM, et al. Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression. Mol Cell Biol. 2011;31(6):1225\u201339.","journal-title":"Mol Cell Biol"},{"key":"4813_CR15","doi-asserted-by":"crossref","unstructured":"Su S, Ndiaye MA, Guzm\u00e1n-P\u00e9rez G et al. Potential tumor suppressor role of polo-like kinase 5 in cancer. Cancers (Basel). 2023;15(22):5457.","DOI":"10.3390\/cancers15225457"},{"key":"4813_CR16","doi-asserted-by":"publisher","first-page":"144097","DOI":"10.1016\/j.gene.2019.144097","volume":"721","author":"Z Ran","year":"2019","unstructured":"Ran Z, Chen W, Shang J, et al. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis. Gene. 2019;721:144097.","journal-title":"Gene"},{"issue":"3","key":"4813_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neo.2018.01.004","volume":"20","author":"EM Matthew","year":"2018","unstructured":"Matthew EM, Yang Z, Peri S, et al. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling. Neoplasia. 2018;20(3):244\u201355.","journal-title":"Neoplasia"},{"issue":"1","key":"4813_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s13046-019-1418-2","volume":"38","author":"B Ou","year":"2019","unstructured":"Ou B, Sun H, Zhao J, et al. Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90\/STAT3\/HK2 signaling. J Exp Clin Cancer Res. 2019;38(1):426.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4813_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/ol.2022.13389","volume":"24","author":"Z Duan","year":"2022","unstructured":"Duan Z, Cai L, Cao J, et al. Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer. Oncol Lett. 2022;24(2):269.","journal-title":"Oncol Lett"},{"key":"4813_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cancergen.2022.09.007","volume":"268\u2013269","author":"W Jiawei","year":"2022","unstructured":"Jiawei W, Xiajun B, Tian S, et al. Comprehensive analysis of PLKs expression and prognosis in breast cancer. Cancer Genet. 2022;268\u2013269:83\u201392.","journal-title":"Cancer Genet"},{"key":"4813_CR21","doi-asserted-by":"crossref","unstructured":"Poyil PK, Siraj AK, Padmaja D et al. Polo-like kinase 1 predicts lymph node metastasis in Middle Eastern colorectal cancer patients; its inhibition reverses 5-Fu resistance in colorectal cancer cells. Cells. 2024;13(20):1700.","DOI":"10.3390\/cells13201700"},{"issue":"2","key":"4813_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/ijo.2018.4659","volume":"54","author":"Z Liao","year":"2019","unstructured":"Liao Z, Zhang H, Fan P, et al. High PLK4 expression promotes tumor progression and induces epithelial\u2013mesenchymal transition by regulating the Wnt\/\u03b2\u2013catenin signaling pathway in colorectal cancer. Int J Oncol. 2019;54(2):479\u201390.","journal-title":"Int J Oncol"},{"issue":"3","key":"4813_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/1878-0261.13610","volume":"18","author":"PK Poyil","year":"2024","unstructured":"Poyil PK, Siraj AK, Padmaja D, et al. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects. Mol Oncol. 2024;18(3):691\u2013706.","journal-title":"Mol Oncol"},{"issue":"1","key":"4813_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13046-020-01750-4","volume":"39","author":"W Alafate","year":"2020","unstructured":"Alafate W, Xu D, Wu W, et al. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling. J Exp Clin Cancer Res. 2020;39(1):239.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10\u201312","key":"4813_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/17520363.2024.2347192","volume":"18","author":"W Zhou","year":"2024","unstructured":"Zhou W, Wang J, Tian F, et al. High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer. Biomark Med. 2024;18(10\u201312):523\u201333.","journal-title":"Biomark Med"},{"issue":"1","key":"4813_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12905-024-02911-9","volume":"24","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Wang M, Chen M. Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection. BMC Womens Health. 2024;24(1):101.","journal-title":"BMC Womens Health"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04813-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04813-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04813-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:27:30Z","timestamp":1778027250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04813-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4813"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04813-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xingtai Central Hospital (approval number: 2021-KY-29), and carried out according to the Declaration of Helsinki. The patients or immediate family members provided the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"696"}}